Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Apomorphine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Antigen Testing for Rapid Detection of Coronavirus Disease 2019 (COVID-19) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Antigen Leukocyte Antibody Test (ALCAT) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Antibody Tests for Neurologic Diseases | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Anti-Rheumatic Biologicals | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Anti-CCP Testing for Rheumatoid Arthritis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Analysis of Proteomic Patterns for Early Detection of Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Analysis of MGMT Promoter Methylation in Malignant Gliomas | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Amtagvi (lifileucel) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Amniotic Membrane and Amniotic Fluid | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ambulance and Medical Transport Services | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Alpha-1 Proteinase Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allograft Injection for Degenerative Disc Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allogeneic Pancreas Transplant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allergy Tests of Uncertain Efficacy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allergy Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Allergy Immunotherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Albendazole | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Akynzeo (netupitant and palonosetron) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Agents for Recurrent Clostridioides Difficile | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adoptive Immunotherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adjunctive Techniques for Screening, Surveillance, and Risk Classification of Barrett Esophagus and Esophageal Dysplasia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Adakveo (crizanlizumab-tmca) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Acute and Maintenance Tocolysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Actimmune (interferon gamma-1b) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Actigraphy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | ACTH Gel (Repository Corticotropin Injection) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Acoustic Cardiography | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | ACL Inhibitors and Combinations | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Accelerated Breast Irradiation and Brachytherapy Boost After Breast-Conserving Surgery for Early-Stage Breast Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Absorbable Nasal Implant for Treatment of Nasal Valve Collapse | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Vision Services prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Vertebral Axial Decompression prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Vagus Nerve Stimulation prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Tumor Treatment Field Therapy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Tumor Markers for diagnosis and management of cancer prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Trigger Point and Tender Point Injections prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Treatment of Varicose Veins and Venous Insufficiency prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Treatment of Tinnitus prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Treatment of Tarlov Cyst | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Treatment of Congenital Athymia | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Transpupillary Thermotherapy for Treatment of Choroidal Neovascularization prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Transcranial Magnetic Stimulation as a Treatment of Depression prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Transcatheter Arterial Chemoembolization - TACE - to Treat Primary or Metastatic Liver Malignancies prn | New policy |